262 related articles for article (PubMed ID: 18001769)
1. Structural basis for catalysis by onconase.
Lee JE; Bae E; Bingman CA; Phillips GN; Raines RT
J Mol Biol; 2008 Jan; 375(1):165-77. PubMed ID: 18001769
[TBL] [Abstract][Full Text] [Related]
2. Contribution of active-site residues to the function of onconase, a ribonuclease with antitumoral activity.
Lee JE; Raines RT
Biochemistry; 2003 Oct; 42(39):11443-50. PubMed ID: 14516195
[TBL] [Abstract][Full Text] [Related]
3. Residues involved in the catalysis, base specificity, and cytotoxicity of ribonuclease from Rana catesbeiana based upon mutagenesis and X-ray crystallography.
Leu YJ; Chern SS; Wang SC; Hsiao YY; Amiraslanov I; Liaw YC; Liao YD
J Biol Chem; 2003 Feb; 278(9):7300-9. PubMed ID: 12499382
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes.
Singh UP; Ardelt W; Saxena SK; Holloway DE; Vidunas E; Lee HS; Saxena A; Shogen K; Acharya KR
J Mol Biol; 2007 Aug; 371(1):93-111. PubMed ID: 17560606
[TBL] [Abstract][Full Text] [Related]
5. Contribution of structural peculiarities of onconase to its high stability and folding kinetics.
Arnold U; Schulenburg C; Schmidt D; Ulbrich-Hofmann R
Biochemistry; 2006 Mar; 45(11):3580-7. PubMed ID: 16533040
[TBL] [Abstract][Full Text] [Related]
6. His...Asp catalytic dyad of ribonuclease A: structure and function of the wild-type, D121N, and D121A enzymes.
Schultz LW; Quirk DJ; Raines RT
Biochemistry; 1998 Jun; 37(25):8886-98. PubMed ID: 9636030
[TBL] [Abstract][Full Text] [Related]
7. The structural integrity exerted by N-terminal pyroglutamate is crucial for the cytotoxicity of frog ribonuclease from Rana pipiens.
Liao YD; Wang SC; Leu YJ; Wang CF; Chang ST; Hong YT; Pan YR; Chen C
Nucleic Acids Res; 2003 Sep; 31(18):5247-55. PubMed ID: 12954760
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of the ribonuclease MC1 mutants N71T and N71S in complex with 5'-GMP: structural basis for alterations in substrate specificity.
Numata T; Suzuki A; Kakuta Y; Kimura K; Yao M; Tanaka I; Yoshida Y; Ueda T; Kimura M
Biochemistry; 2003 May; 42(18):5270-8. PubMed ID: 12731868
[TBL] [Abstract][Full Text] [Related]
9. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen bonding and catalysis: a novel explanation for how a single amino acid substitution can change the pH optimum of a glycosidase.
Joshi MD; Sidhu G; Pot I; Brayer GD; Withers SG; McIntosh LP
J Mol Biol; 2000 May; 299(1):255-79. PubMed ID: 10860737
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
[TBL] [Abstract][Full Text] [Related]
12. Coulombic effects of remote subsites on the active site of ribonuclease A.
Fisher BM; Schultz LW; Raines RT
Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
[TBL] [Abstract][Full Text] [Related]
13. His...Asp catalytic dyad of ribonuclease A: conformational stability of the wild-type, D121N, D121A, and H119A enzymes.
Quirk DJ; Park C; Thompson JE; Raines RT
Biochemistry; 1998 Dec; 37(51):17958-64. PubMed ID: 9922164
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Onconase at 1.1 Å resolution--insights into substrate binding and collective motion.
Holloway DE; Singh UP; Shogen K; Acharya KR
FEBS J; 2011 Nov; 278(21):4136-49. PubMed ID: 21895975
[TBL] [Abstract][Full Text] [Related]
15. Onconase cytotoxicity relies on the distribution of its positive charge.
Turcotte RF; Lavis LD; Raines RT
FEBS J; 2009 Jul; 276(14):3846-57. PubMed ID: 19523116
[TBL] [Abstract][Full Text] [Related]
16. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
[TBL] [Abstract][Full Text] [Related]
17. The importance of dynamic effects on the enzyme activity: X-ray structure and molecular dynamics of onconase mutants.
Merlino A; Mazzarella L; Carannante A; Di Fiore A; Di Donato A; Notomista E; Sica F
J Biol Chem; 2005 May; 280(18):17953-60. PubMed ID: 15728177
[TBL] [Abstract][Full Text] [Related]
18. Coulombic forces in protein-RNA interactions: binding and cleavage by ribonuclease A and variants at Lys7, Arg10, and Lys66.
Fisher BM; Ha JH; Raines RT
Biochemistry; 1998 Sep; 37(35):12121-32. PubMed ID: 9724524
[TBL] [Abstract][Full Text] [Related]
19. The folding pathway of onconase is directed by a conserved intermediate.
Schulenburg C; Löw C; Weininger U; Mrestani-Klaus C; Hofmann H; Balbach J; Ulbrich-Hofmann R; Arnold U
Biochemistry; 2009 Sep; 48(35):8449-57. PubMed ID: 19655705
[TBL] [Abstract][Full Text] [Related]
20. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
